Currently, over 140 hospitals and universities are conducting glycocalyx research using GlycoCheck™ and the Glycocalyx Research Institute's glycocalyx-restoring nutraceuticals.
The studies are focused on the following health issues: Type 2 Diabetes, Hypertension, Stroke, Kidney Failure, Syndrome X, Sepsis/Septic Shock, Inflammatory Disease, Malaria/Dengue, and Obesity.
The research indicates that glycocalyx health is crucial for overall well-being and in managing diseases related to aging. GlycoCheck™ effectively measures glycocalyx health, and the nutraceuticals developed by Dr. Vink and Robert Long aid in restoring it.
